Archive · 26 Sep 2025
Indian Veterinary Vaccine Makers Unite to Boost Industry
Several Indian companies that make vaccines for animals have created a new group called VVIMA.
This group will work with the government to improve the animal vaccine industry.
Their goal is to ensure high-quality vaccines are made in India, making the country a world leader in this field.
Key companies involved include Hester Biosciences and Indian Immunologicals.
The market for these vaccines in India is worth a lot of money, and even more globally.
The organization hopes to boost the research, development, and production of animal vaccines.
Veterinary vaccine companies formed the Veterinary Vaccine India Manufacturers Association (VVIMA).
The association aims to collaborate with policymakers and stakeholders.
VVIMA envisions positioning India as a global hub for animal vaccines.
Rajiv Gandhi of Hester Biosciences is the President of VVIMA.
The Indian veterinary vaccine market is worth ₹2,000 crore.
- Who
- Veterinary vaccine manufacturers
- What
- Formed the Veterinary Vaccine India Manufacturers Association (VVIMA).
- When
- Announced on September 26, 2025.
- Where
- India
- Why
- To collaborate with policymakers and become a global hub.
- Association Name
- Veterinary Vaccine India Manufacturers Association (VVIMA)
- Purpose
- To collaborate with policymakers and stakeholders
- President
- Rajiv Gandhi, CEO of Hester Biosciences
- Vice President
- K Anand Kumar, MD of Indian Immunologicals
- Estimated Indian Market
- ₹2,000 crore
- Estimated Global Market
- Over ₹1 lakh crore
- Member Companies
- Hester Biosciences, Indian Immunologicals, Biovet, Brilliant Bio Pharma, Globion India, Indovax, Venkateshwara Hatcheries